Literature DB >> 6833173

The in-vitro activity of O-demethylfortimicin.

H C Neu.   

Abstract

The activity of O-demethylfortimicin against ampicillin, cefazolin and carbenicillin resistant bacteria was determined. O-Demethylfortimicin showed excellent in-vitro activity against Escherichia coli, Klebsiella pneumoniae, Enterobacter cloacae, Ent. agglomerans, Ent. aerogenes, Citrobacter freundii, Proteus vulgaris, Morganella, and Providencia inhibiting these organisms at less than or equal to 3.1 mg/l. It was particularly effective against Ent. cloacae and Serratia marcescens that were resistant to cefotaxime, cefoperazone and moxalactam. O-Demethylfortimicin did not show particularly good activity against Pseudomonas aeruginosa. Acinetobacter or other Pseudomonas species, MIC90 values were 100 mg/l. Combination of O-demethylfortimicin and ticarcillin or cefsulodin tested against Ps. aeruginosa were primarily indifferent. Combination of O-demethylfortimicin and ticarcillin showed partial synergy for 65% of Enterobacter isolates.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6833173     DOI: 10.1093/jac/11.2.181

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  1 in total

1.  3-0-demethyl fortimicin A: in vitro activity and interpretive zone standards for disk diffusion susceptibility tests.

Authors:  A L Barry; R N Jones; C Thornsberry; T L Gavan; E H Gerlach; H M Sommer
Journal:  Eur J Clin Microbiol       Date:  1984-12       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.